Items where authors include "Cocks, K"

Article

Musoro, JZ, Coens, C, Sprangers, MAG et al. (18 more authors) (2023) Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types. European Journal of Cancer, 188. pp. 171-182. ISSN 0959-8049

Cocks, K, Wells, JR, Johnson, C et al. (15 more authors) (2023) Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. European Journal of Cancer, 178. pp. 128-138. ISSN 0959-8049

Koller, M, Musoro, JZ, Tomaszewski, K et al. (8 more authors) (2022) Corrigendum to “Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials” [Lung Cancer 167C (2022) 65–72]. Lung Cancer, 171. p. 126. ISSN 0169-5002

Koller, M, Musoro, JZ, Tomaszewski, K et al. (8 more authors) (2022) Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials. Lung Cancer. ISSN 0169-5002

Gamper, EM, Musoro, JZ, Coens, C et al. (9 more authors) (2021) Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials. BMC cancer, 21 (1). 1083. ISSN 1471-2407

Dirven, L, Musoro, JZ, Coens, C et al. (13 more authors) (2021) Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients. Neuro-Oncology, 23 (8). pp. 1327-1336. ISSN 1522-8517

Musoro, JZ, Sodergren, SC, Coens, C et al. (11 more authors) (2020) Minimally important differences for interpreting the EORTC QLQ‐C30 in advanced colorectal cancer patients treated with chemotherapy. Colorectal Disease, 22 (12). pp. 2278-2287. ISSN 1462-8910

Musoro, JZ, Coens, C, Greimel, E et al. (10 more authors) (2020) Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer. Gynecologic Oncology, 159 (2). pp. 515-521. ISSN 0090-8258

Musoro, JZ, Coens, C, Singer, S et al. (12 more authors) (2020) Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer. Head & Neck, 42 (11). pp. 3141-3152. ISSN 1043-3074

Coens, C, Pe, M, Dueck, AC et al. (32 more authors) (2020) International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. The Lancet Oncology, 21 (2). e83-e96. ISSN 1470-2045

Musoro, JZ, Coens, C, Frederic, F et al. (9 more authors) (2019) Minimally important differences for interpreting EORTC QLQ-C30 scores in patients with advanced breast cancer. JNCI: Journal of the National Cancer Institute, 3 (3). pkz037. ISSN 0027-8874

Bottomley, A, Pe, M, Sloan, J et al. (38 more authors) (2018) Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials. Clinical Trials, 15 (6). pp. 624-630. ISSN 1740-7745

Musoro, JZ, Bottomley, A, Coens, C et al. (8 more authors) (2018) Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma. European Journal of Cancer, 104. pp. 169-181. ISSN 0959-8049

Pe, M, Dorme, L, Coens, C et al. (29 more authors) (2018) Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. The Lancet Oncology, 19 (9). E459-E469. ISSN 1470-2045

Thyer, NJ, Watson, J, Jackson, C et al. (10 more authors) (2018) Randomised controlled feasibility trial of the Active Communication Education programme plus hearing aid provision versus hearing aid provision alone (ACE to HEAR): a study protocol. BMJ Open, 8 (7). e021502. ISSN 2044-6055

Musoro, ZJ, Hamel, J-F, Ediebah, DE et al. (10 more authors) (2018) Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol. BMJ Open, 8 (1). e019117.

Lawton, R orcid.org/0000-0002-5832-402X, O'Hara, JK orcid.org/0000-0001-5551-9975, Sheard, L et al. (9 more authors) (2017) Can patient involvement improve patient safety? A cluster randomised control trial of the Patient Reporting and Action for a Safe Environment (PRASE) intervention. BMJ Quality and Safety, 26 (8). pp. 622-631. ISSN 2044-5415

Sheard, L, O'Hara, J orcid.org/0000-0001-5551-9975, Armitage, G et al. (5 more authors) (2016) Erratum to: Evaluating the PRASE patient safety intervention - a multi-centre, cluster trial with a qualitative process evaluation: study protocol for a randomised controlled trial. Trials, 17. 605. ISSN 1745-6215

O’Hara, JK, Lawton, RJ orcid.org/0000-0002-5832-402X, Armitage, G et al. (7 more authors) (2016) The patient reporting and action for a safe environment (PRASE) intervention: a feasibility study. BMC Health Services Research, 16 (1). 676. ISSN 1472-6963

Bottomley, A, Pe, M, Sloan, J et al. (36 more authors) (2016) Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncology, 17 (11). e510-e514. ISSN 1470-2045

Moverley, A, Coates, L, Marzo-Ortega, H et al. (5 more authors) (2015) A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F)). Clinical Rheumatology, 34 (8). pp. 1407-1412. ISSN 0770-3198

Lawton, R orcid.org/0000-0002-5832-402X, O'Hara, JK orcid.org/0000-0001-5551-9975, Sheard, L et al. (4 more authors) (2015) Can staff and patient perspectives on hospital safety predict harm-free care? An analysis of staff and patient survey data and routinely collected outcomes. BMJ Quality and Safety, 24 (6). pp. 369-376. ISSN 2044-5415

Kingsbury, SR, Tharmanathan, P, Arden, NK et al. (17 more authors) (2015) Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): Study protocol for a randomized controlled trial. Trials, 16. 77. 1 - 14. ISSN 1745-6215

Sheard, L, O'Hara, J orcid.org/0000-0001-5551-9975, Armitage, G et al. (5 more authors) (2014) Evaluating the PRASE patient safety intervention - a multi-centre, cluster trial with a qualitative process evaluation: study protocol for a randomised controlled trial. Trials, 15 (1). 2282. ISSN 1745-6215

Velikova, G, Keding, A, Harley, C et al. (6 more authors) (2010) Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial. European Journal of Cancer, 46 (13). 2381 - 2388 . ISSN 1879-0852

Briggs, M, Bennett, MI, Cocks, K et al. (1 more author) (2007) Painful leg ulceration: a prospective, longitudinal cohort study. Wound Repair and Regeneration, 15 (2). 186 - 191 . ISSN 1067-1927

Proceedings Paper

Musoro, JZ, Coens, C, Sprangers, MAG et al. (14 more authors) (2022) Synthesis of anchor-based minimally important differences (MID) for the EORTC QLQ-C30 scales across nine cancer sites. In: Quality of Life Research. 29th Annual Conference of the International Society for Quality of Life Research, 19-22 Oct 2022, Prague, Czech Republic. Springer , S47-S48.

Buckley, H, Cocks, K, Lawton, R et al. (6 more authors) (2015) Outcomes to measure patient safety: the patient reporting and action for a safe environment (PRASE) trial. In: Trials. 3rd International Clinical Trials Methodology Conference, 16 Nov 2015 - 17 Nov 2016, Glasgow, UK. BioMed Central , pp. 37-38.